Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Micronized progesterone vs medroxyprogesterone acetate in premature ovarian failure
2012-004511-30Phase 4Completed
- Sponsor
- King's College Hospital
- Start
- Nov 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in ovarian hypofunction (POI) comparing Micronized progesterone with Medroxyprogesterone acetate (2 arms). Primary endpoint: vascular elasticity. Started Nov 2012; status: completed.
02
Drugs
progesteronemedroxyprogesterone acetate
03
Conditions
ovarian hypofunction (POI)
Beyond the preview
Go deeper on 2012-004511-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004511-30.